VIMTALABSNSEVimta Labs Limited· PharmaceuticalsMinimalNeutral
Announced Tue, 31 Mar · 15:31 IST

Vimta Labs Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

VIMTALABS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+8.3%1-day move
₹379.15
prior close
₹397.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+2.2+2.7+2.7+1.7+8.3+9.4+11.0+17.5+16.0+21.9+19.8+26.3+20.8+53.5
Up moveDown movePending
AI summary

Vimta Labs Limited has informed the stock exchange that its trading window will remain closed starting April 1, 2026, until 48 hours after the declaration of its audited financial results for the fourth quarter and full year ended March 31, 2026. This closure applies to all designated persons, their immediate relatives, and all connected persons under the company's insider trading code. The intimation is issued in compliance with SEBI's Prohibition of Insider Trading Regulations, 2015. The communication was signed by the Company Secretary and Compliance Officer, Sujani Vasireddi, on March 31, 2026.

Likely market impact

This is a routine regulatory disclosure and does not directly impact shareholders. However, it signals that the company's Q4 and FY26 audited results are forthcoming, which investors should watch for as a potential near-term catalyst for the stock.